Shangxun Xie

Nanjing Drum Tower Hospital

Papers

2

Total Citations

24

H-Index

2

About

Shangxun Xie is a urologic surgeon and researcher whose work focuses on advancing minimally invasive surgical techniques for complex urologic cancers, particularly in elderly and high-risk patient populations. Xie’s major contributions center on demonstrating the safety and efficacy of robot-assisted surgery for bladder and kidney cancers, with a special emphasis on expanding treatment options for patients over 80 years old. In a landmark comparative study (17 citations), Xie showed that robot-assisted radical cystectomy yields comparable perioperative and survival outcomes in octogenarians versus younger patients, challenging age-based treatment biases. Additionally, Xie pioneered the use of robotic-assisted laparoscopic tumor enucleation for renal hilar tumors (7 citations), developing novel renorrhaphy techniques that preserve renal function while achieving oncologic control. This work has helped establish robotic enucleation as a feasible, nephron-sparing alternative for anatomically challenging tumors. Xie’s research is notable for its direct clinical impact, providing evidence-based guidance for surgeons treating aging populations with urologic malignancies. By systematically evaluating outcomes in vulnerable groups and refining surgical approaches, Xie has contributed to making advanced robotic procedures more accessible and safer for patients who might otherwise be denied curative surgery.

Research Focus

Key Achievements

2
H-Index
2
Papers
24
Total Citations
12
Avg Citations/Paper
🏆 Most Cited Paper
A comparative study of perioperative and survival outcomes of robot-assisted radical cystectomy in patients over 80 and under 80 years old
17 citations · 2021
📈 Most Prolific Year: 2021 (2 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Nanjing Drum Tower Hospital

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago